Astralex Pharmaceuticals · Est. 2026 · Pan-India
Scientifically curated healthcare solutions for modern India — rooted in legacy, driven by innovation.
4+
Products
3
Generations
Pan‑IN
Reach
2026
Founded
Scroll
Astralex Pharmaceuticals · Est. 2026 · Pan-India
Scientifically curated healthcare solutions for modern India — rooted in legacy, driven by innovation.
Astralex is rooted in a legacy of care that began in Puri, where our founder's grandfather established Janata Medicines — a retail pharmacy dedicated to the everyday healthcare needs of the community. The word "Janata" means "the people," and it remains the soul of everything we do.
We exist to be an active partner in patients' wellness journeys, carrying forward a family legacy of care, support, and service to the people across India.
Comprehensive diabetes solutions formulated for optimal glycemic control and patient outcomes.
Trusted dual-action therapy for effective glycemic control — combining sulphonylurea and biguanide mechanisms for comprehensive blood sugar management.
Triple-action formula specifically targeting post-meal glucose spikes — adding an alpha-glucosidase inhibitor for enhanced postprandial control.
Advanced triple therapy for multi-pathway glycemic control — combining SGLT-2 inhibition, DPP-4 inhibition, and insulin sensitization.
Powerful triple combination specifically addressing insulin resistance — integrating thiazolidinedione action for patients with significant IR.
Every product is designed with evidence-based combinations to address multiple metabolic pathways simultaneously for superior outcomes.
Formulations built on established active pharmaceutical ingredients with decades of clinical evidence supporting their safety and efficacy.
Only pharmaceutical-grade raw materials sourced from GMP-compliant manufacturers, ensuring consistent quality and purity in every batch.
Optimized drug delivery systems ensuring maximum absorption and consistent plasma levels, translating to better clinical outcomes.